nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprazolam—CYP3A7—Vincristine—muscle cancer	0.162	0.239	CbGbCtD
Alprazolam—CYP3A7-CYP3A51P—Vincristine—muscle cancer	0.162	0.239	CbGbCtD
Alprazolam—CYP3A5—Vincristine—muscle cancer	0.121	0.179	CbGbCtD
Alprazolam—CYP3A5—Etoposide—muscle cancer	0.111	0.164	CbGbCtD
Alprazolam—CYP3A4—Vincristine—muscle cancer	0.0473	0.07	CbGbCtD
Alprazolam—CYP3A4—Etoposide—muscle cancer	0.0433	0.0641	CbGbCtD
Alprazolam—CYP3A4—Doxorubicin—muscle cancer	0.0296	0.0437	CbGbCtD
Alprazolam—Oedema—Vincristine—muscle cancer	0.00112	0.00344	CcSEcCtD
Alprazolam—Infection—Vincristine—muscle cancer	0.00111	0.00342	CcSEcCtD
Alprazolam—Osteoarthritis—Methotrexate—muscle cancer	0.0011	0.0034	CcSEcCtD
Alprazolam—Nervous system disorder—Vincristine—muscle cancer	0.00109	0.00338	CcSEcCtD
Alprazolam—Hepatic function abnormal—Doxorubicin—muscle cancer	0.00109	0.00337	CcSEcCtD
Alprazolam—Decreased appetite—Dactinomycin—muscle cancer	0.00109	0.00335	CcSEcCtD
Alprazolam—Hyperhidrosis—Vincristine—muscle cancer	0.00108	0.00333	CcSEcCtD
Alprazolam—Fatigue—Dactinomycin—muscle cancer	0.00108	0.00332	CcSEcCtD
Alprazolam—Back pain—Etoposide—muscle cancer	0.00107	0.00331	CcSEcCtD
Alprazolam—Muscle spasms—Etoposide—muscle cancer	0.00106	0.00329	CcSEcCtD
Alprazolam—Anorexia—Vincristine—muscle cancer	0.00106	0.00328	CcSEcCtD
Alprazolam—Hepatic failure—Doxorubicin—muscle cancer	0.00106	0.00328	CcSEcCtD
Alprazolam—Irritability—Methotrexate—muscle cancer	0.00105	0.00325	CcSEcCtD
Alprazolam—Mood swings—Methotrexate—muscle cancer	0.00104	0.00322	CcSEcCtD
Alprazolam—Hypotension—Vincristine—muscle cancer	0.00104	0.00322	CcSEcCtD
Alprazolam—Ataxia—Methotrexate—muscle cancer	0.00104	0.0032	CcSEcCtD
Alprazolam—Feeling abnormal—Dactinomycin—muscle cancer	0.00103	0.00318	CcSEcCtD
Alprazolam—Ill-defined disorder—Etoposide—muscle cancer	0.00103	0.00317	CcSEcCtD
Alprazolam—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00102	0.00315	CcSEcCtD
Alprazolam—Hot flush—Doxorubicin—muscle cancer	0.00102	0.00315	CcSEcCtD
Alprazolam—Liver function test abnormal—Methotrexate—muscle cancer	0.00102	0.00314	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00102	0.00314	CcSEcCtD
Alprazolam—Increased appetite—Doxorubicin—muscle cancer	0.00102	0.00313	CcSEcCtD
Alprazolam—Menopausal symptoms—Doxorubicin—muscle cancer	0.00101	0.00312	CcSEcCtD
Alprazolam—Insomnia—Vincristine—muscle cancer	0.00101	0.00312	CcSEcCtD
Alprazolam—Paraesthesia—Vincristine—muscle cancer	0.001	0.00309	CcSEcCtD
Alprazolam—Malaise—Etoposide—muscle cancer	0.000999	0.00308	CcSEcCtD
Alprazolam—Breast disorder—Methotrexate—muscle cancer	0.000995	0.00307	CcSEcCtD
Alprazolam—Vertigo—Etoposide—muscle cancer	0.000995	0.00307	CcSEcCtD
Alprazolam—Abdominal pain—Dactinomycin—muscle cancer	0.000987	0.00305	CcSEcCtD
Alprazolam—Body temperature increased—Dactinomycin—muscle cancer	0.000987	0.00305	CcSEcCtD
Alprazolam—Loss of consciousness—Etoposide—muscle cancer	0.000973	0.00301	CcSEcCtD
Alprazolam—Lethargy—Doxorubicin—muscle cancer	0.000973	0.00301	CcSEcCtD
Alprazolam—Decreased appetite—Vincristine—muscle cancer	0.00097	0.00299	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Vincristine—muscle cancer	0.000963	0.00297	CcSEcCtD
Alprazolam—Fatigue—Vincristine—muscle cancer	0.000962	0.00297	CcSEcCtD
Alprazolam—Convulsion—Etoposide—muscle cancer	0.000959	0.00296	CcSEcCtD
Alprazolam—Constipation—Vincristine—muscle cancer	0.000954	0.00295	CcSEcCtD
Alprazolam—Diplopia—Doxorubicin—muscle cancer	0.000954	0.00294	CcSEcCtD
Alprazolam—Pain in extremity—Doxorubicin—muscle cancer	0.000954	0.00294	CcSEcCtD
Alprazolam—Osteoarthritis—Doxorubicin—muscle cancer	0.000954	0.00294	CcSEcCtD
Alprazolam—Chest pain—Etoposide—muscle cancer	0.000943	0.00291	CcSEcCtD
Alprazolam—Affect lability—Doxorubicin—muscle cancer	0.000939	0.0029	CcSEcCtD
Alprazolam—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000936	0.00289	CcSEcCtD
Alprazolam—Discomfort—Etoposide—muscle cancer	0.000931	0.00288	CcSEcCtD
Alprazolam—Hypersensitivity—Dactinomycin—muscle cancer	0.00092	0.00284	CcSEcCtD
Alprazolam—Abdominal discomfort—Methotrexate—muscle cancer	0.000913	0.00282	CcSEcCtD
Alprazolam—Gastrointestinal pain—Vincristine—muscle cancer	0.000912	0.00282	CcSEcCtD
Alprazolam—Confusional state—Etoposide—muscle cancer	0.000911	0.00281	CcSEcCtD
Alprazolam—Mood swings—Doxorubicin—muscle cancer	0.000903	0.00279	CcSEcCtD
Alprazolam—Infection—Etoposide—muscle cancer	0.000898	0.00277	CcSEcCtD
Alprazolam—Ataxia—Doxorubicin—muscle cancer	0.000897	0.00277	CcSEcCtD
Alprazolam—Asthenia—Dactinomycin—muscle cancer	0.000896	0.00277	CcSEcCtD
Alprazolam—Dysuria—Methotrexate—muscle cancer	0.00089	0.00275	CcSEcCtD
Alprazolam—Upper respiratory tract infection—Methotrexate—muscle cancer	0.000885	0.00273	CcSEcCtD
Alprazolam—Tachycardia—Etoposide—muscle cancer	0.000882	0.00272	CcSEcCtD
Alprazolam—Body temperature increased—Vincristine—muscle cancer	0.000882	0.00272	CcSEcCtD
Alprazolam—Abdominal pain—Vincristine—muscle cancer	0.000882	0.00272	CcSEcCtD
Alprazolam—Liver function test abnormal—Doxorubicin—muscle cancer	0.00088	0.00272	CcSEcCtD
Alprazolam—Skin disorder—Etoposide—muscle cancer	0.000878	0.00271	CcSEcCtD
Alprazolam—Hyperhidrosis—Etoposide—muscle cancer	0.000874	0.0027	CcSEcCtD
Alprazolam—Photosensitivity reaction—Methotrexate—muscle cancer	0.000869	0.00268	CcSEcCtD
Alprazolam—Breast disorder—Doxorubicin—muscle cancer	0.000862	0.00266	CcSEcCtD
Alprazolam—Anorexia—Etoposide—muscle cancer	0.000861	0.00266	CcSEcCtD
Alprazolam—Diarrhoea—Dactinomycin—muscle cancer	0.000854	0.00264	CcSEcCtD
Alprazolam—Nasopharyngitis—Doxorubicin—muscle cancer	0.000853	0.00263	CcSEcCtD
Alprazolam—Infestation NOS—Methotrexate—muscle cancer	0.000849	0.00262	CcSEcCtD
Alprazolam—Infestation—Methotrexate—muscle cancer	0.000849	0.00262	CcSEcCtD
Alprazolam—Drowsiness—Methotrexate—muscle cancer	0.000849	0.00262	CcSEcCtD
Alprazolam—Depression—Methotrexate—muscle cancer	0.000846	0.00261	CcSEcCtD
Alprazolam—Hypotension—Etoposide—muscle cancer	0.000844	0.00261	CcSEcCtD
Alprazolam—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000841	0.0026	CcSEcCtD
Alprazolam—Muscular weakness—Doxorubicin—muscle cancer	0.000841	0.0026	CcSEcCtD
Alprazolam—Influenza—Doxorubicin—muscle cancer	0.000824	0.00255	CcSEcCtD
Alprazolam—Dysphagia—Doxorubicin—muscle cancer	0.000824	0.00255	CcSEcCtD
Alprazolam—Hypersensitivity—Vincristine—muscle cancer	0.000822	0.00254	CcSEcCtD
Alprazolam—Sweating—Methotrexate—muscle cancer	0.000814	0.00251	CcSEcCtD
Alprazolam—Paraesthesia—Etoposide—muscle cancer	0.000811	0.00251	CcSEcCtD
Alprazolam—Dyspnoea—Etoposide—muscle cancer	0.000806	0.00249	CcSEcCtD
Alprazolam—Somnolence—Etoposide—muscle cancer	0.000803	0.00248	CcSEcCtD
Alprazolam—Hepatobiliary disease—Methotrexate—muscle cancer	0.000803	0.00248	CcSEcCtD
Alprazolam—Epistaxis—Methotrexate—muscle cancer	0.000801	0.00247	CcSEcCtD
Alprazolam—Asthenia—Vincristine—muscle cancer	0.0008	0.00247	CcSEcCtD
Alprazolam—Vomiting—Dactinomycin—muscle cancer	0.000794	0.00245	CcSEcCtD
Alprazolam—Rash—Dactinomycin—muscle cancer	0.000787	0.00243	CcSEcCtD
Alprazolam—Decreased appetite—Etoposide—muscle cancer	0.000786	0.00243	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Etoposide—muscle cancer	0.00078	0.00241	CcSEcCtD
Alprazolam—Fatigue—Etoposide—muscle cancer	0.000779	0.00241	CcSEcCtD
Alprazolam—Constipation—Etoposide—muscle cancer	0.000773	0.00239	CcSEcCtD
Alprazolam—Dysuria—Doxorubicin—muscle cancer	0.000771	0.00238	CcSEcCtD
Alprazolam—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.000766	0.00237	CcSEcCtD
Alprazolam—Diarrhoea—Vincristine—muscle cancer	0.000763	0.00236	CcSEcCtD
Alprazolam—Hepatitis—Methotrexate—muscle cancer	0.000762	0.00235	CcSEcCtD
Alprazolam—Pollakiuria—Doxorubicin—muscle cancer	0.000761	0.00235	CcSEcCtD
Alprazolam—Urinary tract disorder—Methotrexate—muscle cancer	0.000752	0.00232	CcSEcCtD
Alprazolam—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000752	0.00232	CcSEcCtD
Alprazolam—Weight increased—Doxorubicin—muscle cancer	0.00075	0.00232	CcSEcCtD
Alprazolam—Urethral disorder—Methotrexate—muscle cancer	0.000747	0.00231	CcSEcCtD
Alprazolam—Weight decreased—Doxorubicin—muscle cancer	0.000746	0.0023	CcSEcCtD
Alprazolam—Feeling abnormal—Etoposide—muscle cancer	0.000745	0.0023	CcSEcCtD
Alprazolam—Nausea—Dactinomycin—muscle cancer	0.000742	0.00229	CcSEcCtD
Alprazolam—Gastrointestinal pain—Etoposide—muscle cancer	0.000739	0.00228	CcSEcCtD
Alprazolam—Dizziness—Vincristine—muscle cancer	0.000738	0.00228	CcSEcCtD
Alprazolam—Infestation—Doxorubicin—muscle cancer	0.000735	0.00227	CcSEcCtD
Alprazolam—Drowsiness—Doxorubicin—muscle cancer	0.000735	0.00227	CcSEcCtD
Alprazolam—Infestation NOS—Doxorubicin—muscle cancer	0.000735	0.00227	CcSEcCtD
Alprazolam—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000729	0.00225	CcSEcCtD
Alprazolam—Erythema multiforme—Methotrexate—muscle cancer	0.00072	0.00222	CcSEcCtD
Alprazolam—Urticaria—Etoposide—muscle cancer	0.000718	0.00222	CcSEcCtD
Alprazolam—Jaundice—Doxorubicin—muscle cancer	0.000716	0.00221	CcSEcCtD
Alprazolam—Abdominal pain—Etoposide—muscle cancer	0.000714	0.00221	CcSEcCtD
Alprazolam—Body temperature increased—Etoposide—muscle cancer	0.000714	0.00221	CcSEcCtD
Alprazolam—Eye disorder—Methotrexate—muscle cancer	0.000712	0.0022	CcSEcCtD
Alprazolam—Tinnitus—Methotrexate—muscle cancer	0.00071	0.00219	CcSEcCtD
Alprazolam—Vomiting—Vincristine—muscle cancer	0.000709	0.00219	CcSEcCtD
Alprazolam—Cardiac disorder—Methotrexate—muscle cancer	0.000707	0.00218	CcSEcCtD
Alprazolam—Sweating—Doxorubicin—muscle cancer	0.000705	0.00218	CcSEcCtD
Alprazolam—Rash—Vincristine—muscle cancer	0.000703	0.00217	CcSEcCtD
Alprazolam—Dermatitis—Vincristine—muscle cancer	0.000703	0.00217	CcSEcCtD
Alprazolam—Headache—Vincristine—muscle cancer	0.000699	0.00216	CcSEcCtD
Alprazolam—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000695	0.00215	CcSEcCtD
Alprazolam—Epistaxis—Doxorubicin—muscle cancer	0.000693	0.00214	CcSEcCtD
Alprazolam—Angiopathy—Methotrexate—muscle cancer	0.000691	0.00213	CcSEcCtD
Alprazolam—Mediastinal disorder—Methotrexate—muscle cancer	0.000687	0.00212	CcSEcCtD
Alprazolam—Chills—Methotrexate—muscle cancer	0.000684	0.00211	CcSEcCtD
Alprazolam—Mental disorder—Methotrexate—muscle cancer	0.000668	0.00206	CcSEcCtD
Alprazolam—Hypersensitivity—Etoposide—muscle cancer	0.000666	0.00206	CcSEcCtD
Alprazolam—Malnutrition—Methotrexate—muscle cancer	0.000663	0.00205	CcSEcCtD
Alprazolam—Nausea—Vincristine—muscle cancer	0.000663	0.00205	CcSEcCtD
Alprazolam—Hepatitis—Doxorubicin—muscle cancer	0.00066	0.00204	CcSEcCtD
Alprazolam—Hypoaesthesia—Doxorubicin—muscle cancer	0.000656	0.00203	CcSEcCtD
Alprazolam—Urinary tract disorder—Doxorubicin—muscle cancer	0.000652	0.00201	CcSEcCtD
Alprazolam—Oedema peripheral—Doxorubicin—muscle cancer	0.00065	0.00201	CcSEcCtD
Alprazolam—Asthenia—Etoposide—muscle cancer	0.000648	0.002	CcSEcCtD
Alprazolam—Connective tissue disorder—Doxorubicin—muscle cancer	0.000648	0.002	CcSEcCtD
Alprazolam—Urethral disorder—Doxorubicin—muscle cancer	0.000647	0.002	CcSEcCtD
Alprazolam—Back pain—Methotrexate—muscle cancer	0.000642	0.00198	CcSEcCtD
Alprazolam—Pruritus—Etoposide—muscle cancer	0.000639	0.00197	CcSEcCtD
Alprazolam—Vision blurred—Methotrexate—muscle cancer	0.000625	0.00193	CcSEcCtD
Alprazolam—Erythema multiforme—Doxorubicin—muscle cancer	0.000624	0.00193	CcSEcCtD
Alprazolam—Diarrhoea—Etoposide—muscle cancer	0.000618	0.00191	CcSEcCtD
Alprazolam—Eye disorder—Doxorubicin—muscle cancer	0.000617	0.0019	CcSEcCtD
Alprazolam—Ill-defined disorder—Methotrexate—muscle cancer	0.000615	0.0019	CcSEcCtD
Alprazolam—Tinnitus—Doxorubicin—muscle cancer	0.000615	0.0019	CcSEcCtD
Alprazolam—Cardiac disorder—Doxorubicin—muscle cancer	0.000612	0.00189	CcSEcCtD
Alprazolam—Angiopathy—Doxorubicin—muscle cancer	0.000599	0.00185	CcSEcCtD
Alprazolam—Malaise—Methotrexate—muscle cancer	0.000598	0.00185	CcSEcCtD
Alprazolam—Dizziness—Etoposide—muscle cancer	0.000598	0.00185	CcSEcCtD
Alprazolam—Vertigo—Methotrexate—muscle cancer	0.000596	0.00184	CcSEcCtD
Alprazolam—Mediastinal disorder—Doxorubicin—muscle cancer	0.000595	0.00184	CcSEcCtD
Alprazolam—Chills—Doxorubicin—muscle cancer	0.000592	0.00183	CcSEcCtD
Alprazolam—Mental disorder—Doxorubicin—muscle cancer	0.000578	0.00178	CcSEcCtD
Alprazolam—Convulsion—Methotrexate—muscle cancer	0.000575	0.00177	CcSEcCtD
Alprazolam—Vomiting—Etoposide—muscle cancer	0.000575	0.00177	CcSEcCtD
Alprazolam—Malnutrition—Doxorubicin—muscle cancer	0.000574	0.00177	CcSEcCtD
Alprazolam—Rash—Etoposide—muscle cancer	0.00057	0.00176	CcSEcCtD
Alprazolam—Dermatitis—Etoposide—muscle cancer	0.000569	0.00176	CcSEcCtD
Alprazolam—Headache—Etoposide—muscle cancer	0.000566	0.00175	CcSEcCtD
Alprazolam—Arthralgia—Methotrexate—muscle cancer	0.000565	0.00174	CcSEcCtD
Alprazolam—Chest pain—Methotrexate—muscle cancer	0.000565	0.00174	CcSEcCtD
Alprazolam—Myalgia—Methotrexate—muscle cancer	0.000565	0.00174	CcSEcCtD
Alprazolam—Tension—Doxorubicin—muscle cancer	0.000564	0.00174	CcSEcCtD
Alprazolam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000561	0.00173	CcSEcCtD
Alprazolam—Discomfort—Methotrexate—muscle cancer	0.000558	0.00172	CcSEcCtD
Alprazolam—Nervousness—Doxorubicin—muscle cancer	0.000558	0.00172	CcSEcCtD
Alprazolam—Back pain—Doxorubicin—muscle cancer	0.000556	0.00172	CcSEcCtD
Alprazolam—Muscle spasms—Doxorubicin—muscle cancer	0.000552	0.00171	CcSEcCtD
Alprazolam—Confusional state—Methotrexate—muscle cancer	0.000546	0.00169	CcSEcCtD
Alprazolam—Vision blurred—Doxorubicin—muscle cancer	0.000541	0.00167	CcSEcCtD
Alprazolam—Infection—Methotrexate—muscle cancer	0.000538	0.00166	CcSEcCtD
Alprazolam—Nausea—Etoposide—muscle cancer	0.000537	0.00166	CcSEcCtD
Alprazolam—Ill-defined disorder—Doxorubicin—muscle cancer	0.000533	0.00165	CcSEcCtD
Alprazolam—Nervous system disorder—Methotrexate—muscle cancer	0.000531	0.00164	CcSEcCtD
Alprazolam—Agitation—Doxorubicin—muscle cancer	0.000528	0.00163	CcSEcCtD
Alprazolam—Skin disorder—Methotrexate—muscle cancer	0.000526	0.00162	CcSEcCtD
Alprazolam—Hyperhidrosis—Methotrexate—muscle cancer	0.000523	0.00162	CcSEcCtD
Alprazolam—Malaise—Doxorubicin—muscle cancer	0.000518	0.0016	CcSEcCtD
Alprazolam—Vertigo—Doxorubicin—muscle cancer	0.000516	0.00159	CcSEcCtD
Alprazolam—Anorexia—Methotrexate—muscle cancer	0.000516	0.00159	CcSEcCtD
Alprazolam—Syncope—Doxorubicin—muscle cancer	0.000515	0.00159	CcSEcCtD
Alprazolam—Palpitations—Doxorubicin—muscle cancer	0.000508	0.00157	CcSEcCtD
Alprazolam—Hypotension—Methotrexate—muscle cancer	0.000506	0.00156	CcSEcCtD
Alprazolam—Loss of consciousness—Doxorubicin—muscle cancer	0.000505	0.00156	CcSEcCtD
Alprazolam—Convulsion—Doxorubicin—muscle cancer	0.000498	0.00154	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000493	0.00152	CcSEcCtD
Alprazolam—Insomnia—Methotrexate—muscle cancer	0.00049	0.00151	CcSEcCtD
Alprazolam—Chest pain—Doxorubicin—muscle cancer	0.000489	0.00151	CcSEcCtD
Alprazolam—Myalgia—Doxorubicin—muscle cancer	0.000489	0.00151	CcSEcCtD
Alprazolam—Arthralgia—Doxorubicin—muscle cancer	0.000489	0.00151	CcSEcCtD
Alprazolam—Anxiety—Doxorubicin—muscle cancer	0.000487	0.0015	CcSEcCtD
Alprazolam—Paraesthesia—Methotrexate—muscle cancer	0.000486	0.0015	CcSEcCtD
Alprazolam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000486	0.0015	CcSEcCtD
Alprazolam—Discomfort—Doxorubicin—muscle cancer	0.000483	0.00149	CcSEcCtD
Alprazolam—Dyspnoea—Methotrexate—muscle cancer	0.000483	0.00149	CcSEcCtD
Alprazolam—Somnolence—Methotrexate—muscle cancer	0.000481	0.00149	CcSEcCtD
Alprazolam—Dry mouth—Doxorubicin—muscle cancer	0.000478	0.00148	CcSEcCtD
Alprazolam—Dyspepsia—Methotrexate—muscle cancer	0.000476	0.00147	CcSEcCtD
Alprazolam—Confusional state—Doxorubicin—muscle cancer	0.000473	0.00146	CcSEcCtD
Alprazolam—Decreased appetite—Methotrexate—muscle cancer	0.000471	0.00145	CcSEcCtD
Alprazolam—Oedema—Doxorubicin—muscle cancer	0.000469	0.00145	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000467	0.00144	CcSEcCtD
Alprazolam—Fatigue—Methotrexate—muscle cancer	0.000467	0.00144	CcSEcCtD
Alprazolam—Infection—Doxorubicin—muscle cancer	0.000466	0.00144	CcSEcCtD
Alprazolam—Shock—Doxorubicin—muscle cancer	0.000461	0.00142	CcSEcCtD
Alprazolam—Nervous system disorder—Doxorubicin—muscle cancer	0.00046	0.00142	CcSEcCtD
Alprazolam—Tachycardia—Doxorubicin—muscle cancer	0.000457	0.00141	CcSEcCtD
Alprazolam—Skin disorder—Doxorubicin—muscle cancer	0.000455	0.00141	CcSEcCtD
Alprazolam—Hyperhidrosis—Doxorubicin—muscle cancer	0.000453	0.0014	CcSEcCtD
Alprazolam—Anorexia—Doxorubicin—muscle cancer	0.000447	0.00138	CcSEcCtD
Alprazolam—Feeling abnormal—Methotrexate—muscle cancer	0.000446	0.00138	CcSEcCtD
Alprazolam—Gastrointestinal pain—Methotrexate—muscle cancer	0.000443	0.00137	CcSEcCtD
Alprazolam—Hypotension—Doxorubicin—muscle cancer	0.000438	0.00135	CcSEcCtD
Alprazolam—Urticaria—Methotrexate—muscle cancer	0.00043	0.00133	CcSEcCtD
Alprazolam—Abdominal pain—Methotrexate—muscle cancer	0.000428	0.00132	CcSEcCtD
Alprazolam—Body temperature increased—Methotrexate—muscle cancer	0.000428	0.00132	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000427	0.00132	CcSEcCtD
Alprazolam—Insomnia—Doxorubicin—muscle cancer	0.000424	0.00131	CcSEcCtD
Alprazolam—Paraesthesia—Doxorubicin—muscle cancer	0.000421	0.0013	CcSEcCtD
Alprazolam—Dyspnoea—Doxorubicin—muscle cancer	0.000418	0.00129	CcSEcCtD
Alprazolam—Somnolence—Doxorubicin—muscle cancer	0.000417	0.00129	CcSEcCtD
Alprazolam—Dyspepsia—Doxorubicin—muscle cancer	0.000413	0.00127	CcSEcCtD
Alprazolam—Decreased appetite—Doxorubicin—muscle cancer	0.000407	0.00126	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000405	0.00125	CcSEcCtD
Alprazolam—Fatigue—Doxorubicin—muscle cancer	0.000404	0.00125	CcSEcCtD
Alprazolam—Constipation—Doxorubicin—muscle cancer	0.000401	0.00124	CcSEcCtD
Alprazolam—Hypersensitivity—Methotrexate—muscle cancer	0.000399	0.00123	CcSEcCtD
Alprazolam—Asthenia—Methotrexate—muscle cancer	0.000388	0.0012	CcSEcCtD
Alprazolam—Feeling abnormal—Doxorubicin—muscle cancer	0.000386	0.00119	CcSEcCtD
Alprazolam—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000383	0.00118	CcSEcCtD
Alprazolam—Pruritus—Methotrexate—muscle cancer	0.000383	0.00118	CcSEcCtD
Alprazolam—Urticaria—Doxorubicin—muscle cancer	0.000372	0.00115	CcSEcCtD
Alprazolam—Abdominal pain—Doxorubicin—muscle cancer	0.000371	0.00114	CcSEcCtD
Alprazolam—Body temperature increased—Doxorubicin—muscle cancer	0.000371	0.00114	CcSEcCtD
Alprazolam—Diarrhoea—Methotrexate—muscle cancer	0.00037	0.00114	CcSEcCtD
Alprazolam—Dizziness—Methotrexate—muscle cancer	0.000358	0.00111	CcSEcCtD
Alprazolam—Hypersensitivity—Doxorubicin—muscle cancer	0.000345	0.00107	CcSEcCtD
Alprazolam—Vomiting—Methotrexate—muscle cancer	0.000344	0.00106	CcSEcCtD
Alprazolam—Rash—Methotrexate—muscle cancer	0.000341	0.00105	CcSEcCtD
Alprazolam—Dermatitis—Methotrexate—muscle cancer	0.000341	0.00105	CcSEcCtD
Alprazolam—Headache—Methotrexate—muscle cancer	0.000339	0.00105	CcSEcCtD
Alprazolam—Asthenia—Doxorubicin—muscle cancer	0.000336	0.00104	CcSEcCtD
Alprazolam—Pruritus—Doxorubicin—muscle cancer	0.000332	0.00102	CcSEcCtD
Alprazolam—Nausea—Methotrexate—muscle cancer	0.000322	0.000993	CcSEcCtD
Alprazolam—Diarrhoea—Doxorubicin—muscle cancer	0.000321	0.00099	CcSEcCtD
Alprazolam—Dizziness—Doxorubicin—muscle cancer	0.00031	0.000957	CcSEcCtD
Alprazolam—Vomiting—Doxorubicin—muscle cancer	0.000298	0.00092	CcSEcCtD
Alprazolam—Rash—Doxorubicin—muscle cancer	0.000296	0.000913	CcSEcCtD
Alprazolam—Dermatitis—Doxorubicin—muscle cancer	0.000295	0.000912	CcSEcCtD
Alprazolam—Headache—Doxorubicin—muscle cancer	0.000294	0.000907	CcSEcCtD
Alprazolam—Nausea—Doxorubicin—muscle cancer	0.000278	0.00086	CcSEcCtD
